Ocular expression of cyclin-dependent kinase 5 in patients with proliferative diabetic retinopathy.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of diabetes investigation"
DOI: 10.1111/jdi.13702
Abstract: AIMS/INTRODUCTION Inhibition of peroxisome proliferator-activated receptor gamma (PPARĪ³) phosphorylation mediated by cyclin-dependent kinase 5 (Cdk5) is one of the main mechanisms of action of antidiabetic drugs. In this study, we analyzed the ocular expression and… read more here.
Keywords: ppar cdk5; pdr; group; p35 ... See more keywords